Biodesix Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Net Income	-52.15	-65.45	-43.16	-31.35	-30.73	-26.17
Depreciation & Amortization	5.51	5.84	3.18	2.9	2.79	1.74
Share-Based Compensation	5.37	5.96	4.94	3.71	0.17	0.14
Other Operating Activities	18.4	8.67	6.81	3.37	6.04	6.61
Operating Cash Flow	-22.87	-44.97	-28.22	-21.37	-21.73	-17.68
Capital Expenditures	-23.06	-3.53	-2.55	-2.18	-1.42	-0.62
Acquisitions	0	0	0	-0.75	-0.46	0
Investing Cash Flow	-23.06	-3.53	-2.55	-2.93	-1.87	-0.62
Share Issuance / Repurchase	28.86	60.16	17.44	73.34	0.05	0.05
Debt Issued / Paid	9.12	12.77	-15.51	16.04	13.04	10.77
Other Financing Activities	-8.85	-14.05	-0.66	-8.25	9.88	8.22
Financing Cash Flow	29.13	58.88	1.26	81.13	22.97	19.03
Net Cash Flow	-16.8	10.38	-29.51	56.84	-0.63	0.74
Free Cash Flow	-45.93	-48.51	-30.77	-23.54	-23.14	-18.29
Free Cash Flow Margin	-93.57%	-126.94%	-56.45%	-51.68%	-94.26%	-89.54%
Free Cash Flow Per Share	-0.56	-1.15	-1.12	-4.87	-95.63	-91.47

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).